Author: Dermax Aesthetic Publish Time: 10-11-2025 Origin: Site
Sotorior, a premium botulinum toxin product from Dermax, has become increasingly popular in aesthetic medicine for its high purity, fast onset, and cost-effectiveness. Sotorior botulinum toxin injection requires more than selecting an injection point. For aesthetic practitioners, learning how to inject Sotorior correctly ensures optimal aesthetic outcomes while maintaining patient safety.
To assist practitioners, Dermax has compiled a comprehensive usage guide on how to inject Sotorior, including pre-treatment assessment, product preparation, injection planning, commonly treated facial areas, aftercare, and key precautions. Because botulinum toxin products and unit systems are not interchangeable, Sotorior should always be prepared and administered according to its current product information, manufacturer instructions, and applicable local regulations.
Sotorior contains Botulinum Toxin Type A, a potent neurotoxin that temporarily relaxes facial muscles responsible for wrinkles and fine lines. Sotorior is provided in powder form and must be reconstituted with sterile saline before injection. This process allows precise control of the dilution ratio, ensuring accurate dosing and predictable results.
One of the key advantages of Sotorior is its high purity and stability, achieved through vacuum-drying technology rather than the traditional freeze-drying method. This minimizes protein denaturation during preparation and preserves toxin activity. As a result, Sotorior maintains consistent potency, quick onset, and smooth diffusion, providing reliable and natural-looking aesthetic outcomes.
Sotorior is available in two specifications: Sotorior 100u and Sotorior 200u. This allows practitioners to choose the appropriate dosage based on the specific needs of their patients, offering flexibility in treatment planning. Generally, the higher volume (200u) provides a more cost-effective option, reducing the cost per unit and enhancing the overall value of the treatment. For more details on buying Sotorior and how to inject it, please contact the Dermax team.
Before injecting Sotorior, it's essential to thoroughly consult with the patient to understand their aesthetic goals and medical history. Assess the treatment areas for any contraindications and obtain informed consent. Prepare the injection site by cleansing it with an antiseptic solution and marking the target areas for precise injections.
A practical pre-treatment assessment should include:
Treatment objectives: Identify whether the primary goal is reducing dynamic lines, modifying visible muscle activity, or improving facial balance.
Facial assessment: Evaluate the relevant muscles at rest and during facial expression rather than selecting injection points based only on the visible wrinkle.
Medical history: Review relevant medical conditions, previous botulinum toxin treatments, medications, allergies, previous adverse reactions, and other factors that may affect treatment planning.
Treatment documentation: Record the baseline appearance, treatment objectives, selected areas, product information, and informed consent according to the clinic's documentation procedures.
Product verification: Confirm the Sotorior product presentation, lot information, storage status, and current product documentation before preparation.
The treatment plan should remain individualized. Injection locations, treatment extent, and product handling should follow the current Sotorior instructions and the practitioner's professional judgment.
Reconstitution Step:
Sotorior comes as a lyophilized (powder) toxin that must be reconstituted before use. Using a sterile syringe, slowly inject 0.9% sodium chloride (normal saline) into the vial—commonly 2.5 mL for a 100-unit vial or 5 mL for a 200-unit vial, depending on the desired concentration. Gently rotate (do not shake) the vial to dissolve the powder completely and ensure even concentration. Avoid vigorous mixing to prevent foaming and loss of potency.
1. Choosing the Right Needle and Syringe
Select an appropriate needle and syringe for the injection. A 30-gauge needle is commonly used for its fine gauge, which minimizes discomfort and allows for precise injections. An insulin syringe to ensure accurate dosing.
2. Dosing and Units
Determine the appropriate dosage of Sotorior toxins based on the treatment area and the severity of the wrinkles or lines. Typical dosing depends on 2 to 4 units per injection point for facial wrinkles. Always refer to Sotorior dosage guidelines.
3. Injection Process
Positioning the Patient: Position the patient comfortably, either seated or lying down, depending on the treatment area.
Skin Stretching: Gently stretch the skin around the injection site to create a smooth surface. This helps in precise placement of the needle and reduces discomfort.
Injection Angle and Depth: Hold the syringe at a 45-degree angle to the skin surface for superficial injections, such as for crow's feet, or at a 90-degree angle for deeper injections, such as for glabellar lines. Insert the needle into the marked point, ensuring it reaches the appropriate depth without hitting underlying structures.
Administering the Toxin: Slowly depress the syringe plunger to inject the botulinum toxin into the target muscle. Avoid injecting too quickly to minimize the risk of diffusion to adjacent muscles. Withdraw the needle gently and apply slight pressure to the injection site with a sterile gauze pad to prevent bruising.
Multiple Injections: If multiple injections are needed, repeat the process at each marked point, ensuring even distribution of the toxin.
When using Sotorior, knowing the right injection sites helps you get better, more natural results. Commonly discussed facial treatment areas include:
Glabellar lines: Lines between the eyebrows associated with activity of the glabellar complex.
Forehead lines: Horizontal dynamic lines associated with frontalis activity. Brow position and the interaction between the frontalis and brow depressor muscles should be considered during treatment planning.
Crow's feet: Lateral canthal lines associated with activity of the orbicularis oculi.
Bunny lines: Dynamic nasal lines that may become more visible during facial expression.
Lower-face concerns: Selected lower-face indications may involve muscles around the chin or mouth corners, but these areas require particularly individualized assessment because treatment can affect facial movement and balance.
The number and location of injection points, treatment extent, and dose should be selected according to the patient's anatomy, muscle activity, treatment goal, and current Sotorior product guidance.
After administering Sotorior, patients should receive clear, clinic-specific aftercare instructions and information about what to expect during the early post-treatment period.
Advise them to avoid touching or massaging the treated area for 24 hours to prevent toxin migration. Additionally, recommend refraining from strenuous activity, alcohol consumption, and heat exposure for 24 to 48 hours. Monitor patients for any adverse reactions and schedule a follow-up appointment for evaluation.
Like other botulinum toxin injections, injection of Sotorior requires careful handling and consideration of various precautions and contraindications to ensure safety and efficacy. Here are the key points to consider:
Known Hypersensitivity: Sotorior is contraindicated in individuals with a known hypersensitivity to botulinum toxin or any of the excipients in the formulation.
Infection at the Injection Site: Do not inject Sotorior into areas with active infection or inflammation.
Neuromuscular Disorders: Patients with neuromuscular disorders such as myasthenia gravis, Eaton-Lambert syndrome, or amyotrophic lateral sclerosis (ALS) should not receive Sotorior due to an increased risk of systemic effects and complications.
Bleeding Disorders: Patients with bleeding disorders or those taking anticoagulant therapy may be at increased risk of bleeding and bruising at the injection site.
Pregnancy and Breastfeeding: The safety of Sotorior in pregnant or breastfeeding women has not been established. It is generally recommended to avoid use during pregnancy and lactation unless absolutely necessary and after thorough risk assessment.
Acute Illness: Postpone treatment in patients with acute illness or in poor general health until they have recovered.
Observation Post-Injection: Monitor the patient for a period after injection to observe any immediate adverse reactions.
For professional guidance on how to inject Sotorior or to purchase Sotorior Botulinum Toxin for your clinic, contact Dermax today.
Botulinum toxin treatment should be individualized rather than performed according to a universal injection template. Current expert recommendations emphasize assessment of facial anatomy, muscle activity, treatment objectives, and individual patient characteristics when determining injection placement and treatment strategy.
For Sotorior, practitioners should use the current product-specific instructions together with appropriate clinical training and professional judgment.
Written by: Dermax Team
Last reviewed: September 2026
